Tranexamic Acid Tablet, Film Coated
FDA Label NDC 63629-8599

39 label sections · Submitted to the FDA by Bryant Ranch Prepack · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Bryant Ranch Prepack for the product Tranexamic Acid (NDC 63629-8599). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2.1 recommended testing prior to tranexamic acid tablets administration, 2.2 recommended dosage, 2.3 dosage recommendations in patients with renal impairment, 3 dosage forms and strengths, 4.1 thromboembolic risk, 4.2 hypersensitivity to tranexamic acid, 5.1 thromboembolic risk, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

How Supplied

Tranexamic acid tablets are provided as white to off-white, oval-shaped, unscored, film coated 650 mg tablets. Each tablet is debossed with “WPI 3720” on one side of the tablet.

NDC: 63629-8599-1: 8 TABLETs in a BOTTLE, PLASTIC

Storage

Store at 20° to 25° C (68° to 77° F). [See USP Controlled Room Temperature].

Repackaged/Relabeled by:

Bryant Ranch Prepack, Inc.

Burbank, CA 91504

Package Label.Principal Display Panel

Tranexamic Acid 650mg Tablet

Label (Lbl636298599)

Label (Lbl636298599)

* Please review the disclaimer below.